eClerx Named a Major Contender in Everest Groups Marketing Services PEAK Matrix 2025
NEW YORK--(BUSINESS WIRE)--#CX--eClerx Services Ltd (ECLERX.NS), a leading productized services company, today…
Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor,…